Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers

Jeffrey M. Jacobson, John S. Greenspan, John Spritzler, Lawrence Fox, John L. Fahey, J. Brooks Jackson, Miriam Chernoff, David A. Wohl, Joseph J. Pulvirenti, Thomas M. Hooton, Cecilia Shikuma, D. Greenspan, F. Aweeka, D. Simpson, A. Wu, N. Ketter, C. Trapnell, L. Purdue, J. McFarland, W. LevyG. Jones, A. Bardequez, R. Clark, N. Quesada, P. J. Andrulis, M. W. Drulak, K. Luykx, C. Van der Horst, S. Forstat, H. Kessler, B. A. Royer, D. Ogata-Arakaki, J. S. Currier, V. T. Clemente, G. J. Vasquez, M. Cruz-Ortiz, R. Delapenha, Y. Butler, L. J. Wheat, B. W. Zwickl, R. Soiero, D. Stein, N. Basgoz, J. Doweiko, V. McAuliffe, J. Dowling, R. Hewitt, D. Blair, S. Canmann, E. Connick, S. P. Raffanti

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers'. Together they form a unique fingerprint.

Medicine & Life Sciences